WATSON 3546 (Aspirin, butalbital, caffeine and codeine 325 mg / 50 mg / 40 mg / 30 mg)
Pill imprint WATSON 3546 has been identified as Aspirin, butalbital, caffeine and codeine 325 mg / 50 mg / 40 mg / 30 mg.
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
See also related documents.
Images for WATSON 3546 (Aspirin, butalbital, caffeine and codeine 325 mg / 50 mg / 40 mg / 30 mg)
- 325 mg / 50 mg / 40 mg / 30 mg
- Blue & Yellow
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 3
FD&C Yellow No. 6
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|23490-6825||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about aspirin/butalbital/caffeine/codeine
- Aspirin, butalbital, caffeine, and codeine
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)